EP3395339B8 |
11 Dec, 2019
|
Rapid Dissolution Formulation Of A Cinacalcet Hcl
|
Sep, 2024
|
11
| |
EP3395340B8 |
11 Dec, 2019
|
Rapid Dissolution Formulation Of Cinacalcet Hcl
|
Sep, 2024
|
9
| |
EP3260117B8 |
27 Nov, 2019
|
Rapid Dissolution Formulation Of A Calcium Receptor-Active Compound
|
Sep, 2024
|
8
| |
EP3578175B1 |
30 Nov, 2022
|
Rapid Dissolution Formulation Of A Calcium Receptor-Active Compound
|
Sep, 2024
|
7
| |
EP3395338B1 |
01 May, 2019
|
Rapid Dissolution Formulation Of Cinacalcet Hcl
|
Sep, 2024
|
7
| |
EP3246017B1 |
24 Mar, 2021
|
Stable Liquid Formulation Of Amg 416 Hcl (Etelcalcetide)
|
Jun, 2034
|
4
| |
EP2382228B1 |
26 Aug, 2020
|
Compositions And Methods Of Treating Inflammatory And Autoimmune Diseases
|
Jan, 2030
|
4
| |
EP3681483B1 |
18 May, 2022
|
Process For Lyophilized Pharmaceutical Formulation Of A Therapeutic Protein
|
Sep, 2038
|
3
| |
EP3666797B1 |
17 May, 2023
|
Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (Pcsk9)
|
Aug, 2028
|
2
| |
EP3658203B1 |
31 Aug, 2022
|
Drug Delivery Device With Gear Module And Related Method Of Assembly
|
Jul, 2038
|
2
| |
EP3464277B1 |
28 Dec, 2022
|
Pegylated Carfilzomib Compounds
|
May, 2037
|
1
| |
EP3381942B1 |
14 Apr, 2021
|
A Method For Treating Melanoma Using A Herpes Simplex Virus And An Immune Checkpoint Inhibitor
|
Aug, 2033
|
1
| |
EP3085386B1 |
24 Jun, 2020
|
Method For Inhibiting Bone Resorption
|
Sep, 2028
|
1
| |
EP2641917B1 |
06 May, 2020
|
Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (Pcsk9)
|
Aug, 2028
|
1
| |